A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)

Clinical trial NCT01482715 · COMPLETED

Trial details

NCT number: NCT01482715
Sponsor: pharmaand GmbH
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer Advanced Solid Tumor With Evidence of Germline or Somatic BRCA

Start date: 2011-11-01
Primary completion: 2019-03-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.